Paola Fortugno
Sigma-Tau
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paola Fortugno.
Current Opinion in Biotechnology | 1996
Riccardo Cortese; Paolo Monaci; Alessandra Luzzago; Claudia Santini; Fabrizia Bartoli; Irene Cortese; Paola Fortugno; Giovanni Galfré; Alfredo Nicosia; Franco Felici
Random peptide libraries displayed on phage are used as a source of peptides for epitope mapping, for the identification of critical amino acids responsible for protein-protein interactions and as leads for the discovery of new therapeutics. Efficient and simple procedures have been devised to select peptides binding to purified proteins, to monoclonal and polyclonal antibodies and to cell surfaces in vivo and in vitro.
International Journal of Cancer | 2003
Olga Minenkova; Andrea Pucci; Emiliano Pavoni; Amedeo De Tomassi; Paola Fortugno; Nicola Gargano; Maurizio Cianfriglia; Stefano Barca; Sabino De Placido; Angelo Martignetti; Franco Felici; Riccardo Cortese; Paolo Monaci
Screening cDNA libraries from solid human tumors with sera of autologous patients (SEREX) has proven to be a powerful approach to identifying tumor antigens recognized by the humoral arm of the immune system. In many cases, application of this methodology has led to the discovery of novel tumor antigens as unknown gene products. We tried to improve the potency of the SEREX approach by combining it with phage‐display technology. We designed a new lambda vector to express protein fragments as N‐terminal fusions to the D capsid protein and generated high‐complexity cDNA libraries from human breast carcinoma cell lines and solid tumors. Screening these phage‐displayed libraries required limited amounts of sera from patients and efficiently identified several tumor antigens specifically reacting with sera from breast cancer patients.
Journal of Immunological Methods | 2000
Lorena Urbanelli; Paola Fortugno; Fabrizia Bartoli; Maurizio Nuzzo; Amedeo De Tomassi; Franco Felici; Paolo Monaci
We have previously screened a phage-displayed random peptide library using sera from patients and identified ligands binding to antibodies specifically associated with the hepatitis C virus infection. The ability of these peptides to detect HCV-specific antibodies was improved through an in vitro procedure which mimics the natural process of antibody affinity maturation operating in secondary immune response. Libraries were generated by mutating the sequence of the original peptide through a protocol that efficiently introduced substitution, insertion and deletion mutations on a single or population of clones. Screening these libraries isolated mutants that displayed increased specific reactivity with a broader range of sera from HCV-infected patients. Several variants of the original peptide were identified which discriminate between the various components of the specific polyclonal response. This methodology to select artificial ligands from RPL using sera and to enhance their diagnostic properties by affinity maturation makes the development of a diagnostic assay to detect disease-associated antibodies feasible, without requiring the natural antigen.
Parasite Immunology | 2002
Helen Melzer; Paola Fortugno; Erfan Mansouri; Franco Felici; Alexandra Marinets; Gerhard Wiedermann; Herwig Kollaritsch; Bernd Ulrich Von Specht; Michael Duchêne
Entamoeba histolytica is the protozoan parasite responsible for intestinal amoebiasis and amoebic liver abscess, which cause significant morbidity and mortality in many countries of the world. Proteophosphoglycans (PPGs, also known as lipophosphoglycans, LPGs, or lipopeptidophosphoglycans, LPPGs) represent dominant surface components of E. histolytica. Passive immunization with a monoclonal antibody (EH5) directed against these components protected SCID mice from amoebic liver abscess, so PPGs might be regarded as vaccine candidates; however, their structure is very complex and only known in part. They are glycosylphosphatidylinositol‐linked polypeptides of unknown sequence carrying glycan side‐chains linked to serine residues via phosphodiester bonds. In order to identify peptide mimics of the E. histolytica PPG antigens, we screened six different phage‐displayed random peptide libraries with the antibody EH5. Various peptide mimics of different length were identified and, in all the peptides, a distinct consensus sequence Gly‐Thr‐His‐Pro‐X‐Leu could be identified. The phages strongly bound to the antibody, and the natural antigen inhibited binding of the phages to antibody EH5. In addition, several of the phages induced a significant immunoglobulin G response against amoebic antigens in immunized mice.
European Journal of Immunology | 1997
Armelle Phalipon; Antonella Folgori; Josette Arondel; Giuseppe Sgaramella; Paola Fortugno; Riccardo Cortese; Philippe J. Sansonetti; Franco Felici
FEBS Journal | 2001
Olga Minenkova; Nicola Gargano; Amedeo De Tomassi; Francesca Bellintani; Andrea Pucci; Paola Fortugno; Elena Fuscaldi; Antonello Pessi; Maria Rapicetta; Michela Miceli; Paola Iudicone; Riccardo Cortese; Franco Felici; Paolo Monaci
Analytical Biochemistry | 2000
Olga Minenkova; Amedeo De Tomassi; Francesca Bellintani; Paola Fortugno; Nicola Gargano; Franco Felici; Paolo Monaci
Research in Immunology | 1998
Armelle Phalipon; Antonella Folgori; Josette Arondel; G. Sgaramella; Paola Fortugno; Riccardo Cortese; Philippe J. Sansonetti; Franco Felici
EMBO Workshop on "Pathogenesis of amoebiasis: from genomics to disease" | 2003
Helen Melzer; M. Binder; P. Rendi-Wagner; Alexandra Marinets; Karin Baier; Paola Fortugno; Franco Felici; Erfan Mansouri; B. . U. Von Specht; Herwig Kollaritsch; Gerhard Wiedermann; Ursula Wiedermann; M. Duchne
Archives of Medical Research | 2000
Helen Melzer; Franco Felici; Erfan Mansouri; Paola Fortugno; Alexandra Marinets; Gerhard Wiedermann; Herwig Kollaritsch; Bernd-Ulrich von Specht; Michael Duchêne